Frank J Beurskens

8PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
Blockade of Complement Cell Lysis and C3d Fixation by Patient HLA-A1 Antibodies: Towards a New Therapy for Prevention of Antibody-Mediated Rejection.

|Oct 22, 2024
Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding.

Nikolaus Frischauf, Jürgen Strasser, Ellen G F Borg

|Apr 11, 2018
Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells".

Patrick J Engelberts, Esther C W Breij, T Valerius

|Feb 17, 2018
Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement.

Deniz Ugurlar, Stuart C Howes, Bart-Jan de Kreuk

|Jan 08, 2017
Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells.

Annalina Tammen, Stefanie Derer, Ralf Schwanbeck

|Nov 04, 2016
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.

Patrick J Engelberts, Marleen Voorhorst, Janine Schuurman

Pageof 2

Frequent Collaborators

5 joint publications

Janine Schuurman

5 joint publications

Paul W H I Parren

4 joint publications

Thomas Valerius

2 joint publications

Patrick J Engelberts